Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-06

Clinical Trial Update: Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial comparing human albumin with cabergoline to prevent ovarian hyperstimulation syndrome in assisted reproductive technology programs has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABERGOLINE (CABERGOLINE)
  • Human Albumin

Snippet

Sponsor: Royan Institute | Conditions: Ovarian Hyperstimulation Syndrome | Phase 1, Phase 2 | Status: COMPLETED